ROSEN, A TRUSTED AND TOP RANKED FIRM, Reminds Vaxart, Inc. Investors of Important Deadline in Securities Class Action - VXRTPRNewsWire • 09/15/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vaxart, Inc. -VXRTPRNewsWire • 09/15/20
Vaxart Gets FDA Sign-Off on Phase 1 Clinical Trial for Its Coronavirus VaccineThe Motley Fool • 09/14/20
Vaxart's stock rallies 15% after it gets clearance to begin human trials of COVID-19 vaccine candidateMarket Watch • 09/14/20
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 ProgramGlobeNewsWire • 09/14/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vaxart (VXRT) Investors with Significant Losses to Contact the Firm, Securities Fraud Class Action Filed and Application Deadline ApproachingNewsfile Corp • 09/11/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vaxart (VXRT) Investors with Significant Losses to Contact the Firm Now, Securities Fraud Class Action Filed and Application Deadline ApproachingNewsfile Corp • 09/10/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Vaxart (VXRT) Investors with Significant Losses to Contact the Firm Now, Securities Fraud Class Action Filed and Important Deadline is ApproachingNewsfile Corp • 09/09/20
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical StudiesGlobeNewsWire • 09/08/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Vaxart, Inc. Investors of Important Deadline in Securities Class Action – VXRTBusiness Wire • 09/06/20
Got $3,000? These 4 Emerging Coronavirus Vaccine Stocks Look Like a BargainThe Motley Fool • 09/05/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Securities Fraud Class Action, Encourages Investors with Significant Losses to Contact its AttorneysNewsfile Corp • 09/04/20